Form D · Other
Formulate Labs, Inc.
Fenton, MO · CIK 0001827318
Offering snapshot reported Jul 10, 2025 · SEC filing
- Reported sold
- $1.39M Offering amount: $6.89M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2025 | Initial | $1,393,516 | No comparison | 21 | SEC filing |
| Oct 7, 2020 | Initial | $1,443,600 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-551363
Source: Form D, filed Jul 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Calacanis | Director |
| Michael Savino | Director |
| Osmaan Shah | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1645 Headland Dr.
Fenton, MO, 63026
Fenton, MO, 63026